Yong-Jie Lu

12PUBLICATIONS
182CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersGene expression (incl. microarray and other genome-wide approaches)Epigenetics (incl. genome methylation and epigenomics)Gene mapping
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Aug 11, 2026
The pre-treatment tumor microenvironment immune status determines Bacillus Calmette-Guerin immunotherapy response in early-stage bladder cancer.

|Feb 13, 2026
High Frequency Loss of 17q11.2 and Downregulation of the Cancer Metastasis Suppression microRNA miR-193a-3p in Prostate Cancer Bone Metastasis.

Elzbieta Stankiewicz, Sarah C McCarley, Xueying Mao

|Jan 26, 2026
Genomic risk model to implement precision prostate cancer screening in clinical care: the ProGRESS study.

Jason L Vassy, Anna M Dornisch, Roshan Karunamuni

|Jan 16, 2026
Circulating tumour cells as a window into lethality in prostate cancer.

Sophia M Abusamra, Thineskrishna Anbarasan, Daniele T Cotton

|May 19, 2025
The development and applications of circulating tumour cells, circulating tumour DNA and other emerging biomarkers for early cancer detection.

David Sinclair Thomas Junior, Junjie Chai, Yong-Jie Lu

|Nov 09, 2023
Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants.

Anqi Wang, Jiayi Shen, Alex A Rodriguez

Pageof 2

Frequent Collaborators

5 joint publications

Jyotsna Batra

5 joint publications

Ana Vega

5 joint publications

Ruth C Travis

5 joint publications

Henrik Gronberg